AKT1 and breast carcinoma: There was research demonstrating that the combination therapy of rapamycin together with resveratrol maintains the inhibition of mTORC1 signaling, which could prevent the upregulation of Akt activation and autophagy to induce the apoptosis of breast cancer cells [62].